CEO Insights Magazine

In Myanmar, where many couples have historically faced emotional and financial strain in seeking fertility treatment abroad, a new approach to reproductive healthcare is taking shape - one that prioritizes accessibility, precision, and local capability.

At the center of this shift is Bhone Pyae Hlaing, CEO of Pulse and Purpose, whose journey has been driven by a clear realization: world-class fertility care should not require leaving one’s country.

By focusing on strengthening infrastructure, ensuring clinical excellence, and bridging global technology with local needs, he enhances Myanmar's reproductive healthcare by providing world-class laboratory equipment and consumables. By bridging global innovation with local needs, he makes advanced fertility solutions attainable and sustainable for families nationwide.

Bhone witnessed firsthand the financial and emotional strain couples endured while seeking IVF treatments - an experience that highlighted a critical gap in Myanmar’s Assisted Reproductive Technology (ART) ecosystem. Motivated to create change, he pursued specialized training in operational management and fertility-focused supply chain logistics to build a strong, localized foundation for fertility centers.

Today, Pulse and Purpose delivers international-standard laboratory equipment and consumables, integrated with advanced genetic testing. Under his leadership, the focus remains clear: providing world-class laboratory equipment and consumables that are affordable and available within the country for fertility centers.

His work is not only delivering equipment and consumables but also reshaping possibilities for families, ensuring that the journey to parenthood no longer requires leaving home.

How has Pulse and Purpose improved success rates for fertility procedures in Myanmar?

At Pulse and Purpose, improving success rates for IUI, IVF, and ICSI begins with strengthening the entire fertility ecosystem. The focus is on ensuring that 'world-class' standards translate into consistent clinical outcomes.

A key contribution lies in maintaining optimal laboratory conditions by supplying internationally certified culture media and consumables, supported by strict Good Distribution Practice (GDP) cold-chain management to preserve their efficacy.

The introduction of Myanmar’s first Preimplantation Genetic Testing (PGT) services has been another major advancement, enabling the selection of the healthiest embryos and significantly improving pregnancy outcomes while reducing risks of miscarriage and genetic disorders.

Additionally, Pulse and Purpose bridges global innovation with local practice through robust logistics and technical support, ensuring clinicians have access to reliable, high-performance tools. This integrated approach makes advanced fertility care more effective, accessible, and affordable within Myanmar.

What challenges do fertility clinics face in Myanmar, and how are you helping address them?

In Myanmar, fertility clinics face three interconnected challenges - supply chain limitations, lab infrastructure gaps, and lack of technical precision. From my perspective, the supply chain is critical, as culture media are highly temperature- sensitive with very short shelf lives.

To address this, we use advanced forecasting, maintain optimal buffer stock, and ensure GDP-compliant cold-chain logistics with strict temperature monitoring to preserve clinical efficacy.

Infrastructure is another concern, as fertility labs require specialized environments. We provide technical guidance to help clinics build cleanrooms with proper air filtration and safe materials, ensuring ideal conditions for embryo development.

Lastly, there is a gap in equipment calibration expertise. We invest in training local engineers internationally and offer ISO-approved calibration and validation services. This ensures that clinics not only have advanced technology but also maintain its precision and consistency over time.

How do you see the Assisted Reproductive Technology (ART) landscape evolving in Myanmar over the next 5–10 years?

I see Myanmar’s ART landscape evolving through a blend of technology, accessibility, and national focus. AI will play an increasingly vital role in selecting the healthiest embryos, enabling more precise, data-driven decisions and improving success rates. At the same time, care will move beyond conventional IVF toward wider adoption of genetic testing like PGT, ensuring healthier pregnancies and outcomes.

I also expect a decentralization of high-quality fertility services, expanding beyond major cities like Yangon and Mandalay into emerging regions. With growing government support, fertility care will become more affordable and recognized as a national priority.

Ultimately, my vision is to position Myanmar as a self-sufficient and globally competitive ART hub, reducing outbound medical travel while attracting international patients to boost the country’s foreign exchange earnings.

Describe your leadership style. What are the guidelines or methodologies you follow as a leader?

My leadership style is rooted in balancing technical excellence with a clear sense of purpose - delivering the highest standards to fertility centers while helping families achieve parenthood. At Pulse and Purpose, I follow three core principles.

First, I lead with a 'standard-first' approach, ensuring strict adherence to global protocols and making sure my team understands their importance. Second, I focus on empowering people through continuous training, investing in both local and international exposure to build strong, self-reliant expertise.

Finally, I emphasize synchronous problem-solving, where logistics, engineering, and clinical teams work together seamlessly.

By aligning precision, people, and collaboration, I ensure that our systems remain reliable and our patients receive consistent, world-class care.

What is the future destination you are heading towards?

My vision is to transform Myanmar into a self-sufficient regional hub for fertility excellence. I aim to make high-quality ART treatments accessible and affordable, ensuring that IVF is not a luxury but an option available to every couple, supported by initiatives like fertility insurance.

We are expanding a network of specialized centers beyond major cities, bringing international-standard care closer to families nationwide. At Pulse and Purpose, we are also building a dedicated training ecosystem to develop skilled local professionals and strengthen long-term expertise.

Ultimately, I want to position Myanmar as a destination for medical tourism and offering world-class outcomes at cost-effective pricing while empowering families to pursue parenthood within their own country.

Bhone Pyae Hlaing, CEO, Pulse and Purpose

Bhone Pyae Hlaing is the CEO of Pulse and Purpose, advancing Myanmar’s ART sector toward global standards. With a background in Engineering Business Management and international education, he combines technical precision with strategic vision, delivering high-quality products and services to fertility centers, and positioning parenthood as an achievable reality for families across Myanmar.